Lansforsakringar Fondforvaltning AB (publ)
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2059323
Stockholm, V7
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$19,601,603
-$5,973,553 QoQ
Shares Held
31,436
-5.0% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#215
of 1,322 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Lansforsakringar Fondforvaltning AB (publ) holds $105,727,306 across 11 Biotechnology names. REGN ranks #2 (18.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
79,627 | $39,553,119 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
31,436 | $19,601,603 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
41,157 | $12,389,491 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
48,442 | $9,072,217 | |
| 5 | RPRX |
Royalty Pharma plc
|
161,125 | $9,034,278 | |
| 6 | INSM |
INSMED Inc
|
63,437 | $6,763,652 | |
| 7 | INCY |
Incyte Corp
|
47,223 | $5,353,199 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
123,352 | $2,680,317 |
All Filings in REGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,601,603 | 31,436 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $25,575,156 | 33,101 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $29,398,984 | 38,088 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $21,548,997 | 38,325 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $19,404,000 | 36,960 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $25,294,360 | 39,882 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $29,656,434 | 41,633 | Shares | Sole | 2025-03-14 | |
| No filing history on record for this holder in this stock. | ||||||